Tandem Diabetes Care, Inc. (TNDM)
| Market Cap | 1.72B |
| Revenue (ttm) | 1.01B |
| Net Income (ttm) | -204.71M |
| Shares Out | 68.33M |
| EPS (ttm) | -3.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,060,718 |
| Open | 24.88 |
| Previous Close | 25.30 |
| Day's Range | 24.32 - 25.39 |
| 52-Week Range | 9.98 - 29.65 |
| Beta | 1.67 |
| Analysts | Buy |
| Price Target | 27.05 (+7.21%) |
| Earnings Date | Feb 19, 2026 |
About TNDM
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It’s flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body. In addition, it offers Tandem Device Updater used to update the pump software from a pe... [Read more]
Financial Performance
In 2025, Tandem Diabetes Care's revenue was $1.01 billion, an increase of 7.93% compared to the previous year's $940.20 million. Losses were -$204.71 million, 113.2% more than in 2024.
Financial StatementsAnalyst Forecast
According to 19 analysts, the average rating for TNDM stock is "Buy." The 12-month stock price target is $27.05, which is an increase of 7.21% from the latest price.
News
Tandem Diabetes Care, Inc. (TNDM) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
Tandem Diabetes Care, Inc. (TNDM) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $265.0 million aggregate principal amou...
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions...
Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition
Tandem Diabetes Care, Inc. delivered strong Q4 '25 results, with revenue and gross margin beats driving a 32% stock surge. TNDM's shift to a pay-as-you-go model will temporarily compress reported reve...
Tandem Diabetes Shares Rise 33% On Earnings Beat, Margin Expansion, Growth Outlook
The stock is moving higher as the broader market is experiencing positive momentum, with the Nasdaq up 0.62% today, contributing to the bullish sentiment.
Tandem Diabetes Care Analysts Boost Their Forecasts After Upbeat Q4 Results
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) reported better-than-expected fourth-quarter financial results on Thursday.
Tandem Diabetes Care, Inc. (TNDM) Q4 2025 Earnings Call Transcript
Tandem Diabetes Care, Inc. (TNDM) Q4 2025 Earnings Call Transcript
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year e...
Tandem Diabetes Care Announces Upcoming Conference Presentations
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the ...
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2025 results after ...
Tandem t:slim Mobile App Now Available in Canada
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--Tandem t:slim mobile application is now available for Android and iOS users in Canada.
Tandem Diabetes Care Announces Appointment of Sandra Beaver to Board of Directors
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Sandra Beaver to...
Tandem Mobi Receives FDA Clearance for Use with Android Smartphones
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administ...
Tandem Diabetes Care, Inc. (TNDM) Q3 2025 Earnings Call Transcript
Tandem Diabetes Care, Inc. ( TNDM) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Susan Morrison - Executive VP & Chief Administrative Officer John Sheridan - President, CEO ...
Tandem Diabetes Care Announces Third Quarter 2025 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 3...
Tandem Diabetes Care Achieves ISO/IEC 27001:2022 Certification, Reinforcing Commitment to Global Data Security Standards
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it achieved ISO/IEC 27001:2022 Cert...
t:slim X2™ Insulin Pump Now Available with Abbott's FreeStyle Libre® 3 Plus Sensor in the United States
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced that the t:slim X2 insulin pump, featuring...
TNDM Investors Have Opportunity to Join Tandem Diabetes Care, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES , Oct. 16, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tandem Diabetes Care...
Tandem Diabetes Care to Announce Third Quarter 2025 Financial Results on November 6, 2025
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2025 results after the financial m...
Tandem t:slim X2 Insulin Pump Now Compatible With Lyumjev Ultra-Rapid Acting Insulin in the United States
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--t:slim X2 insulin pump with Control-IQ+ technology now cleared for use with Lyumjev ultra-rapid acting insulin in the U.S.
Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--Tandem Diabetes Care® (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today announced the publication of a study, "Adults wit...
Tandem Diabetes Care, Inc. (TNDM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 9:15 AM EDT Company Participants John Sheridan - President, CEO & Director Leigh Vo...
Tandem t:slim Mobile App Now Authorized by Health Canada for iPhone and Android Phones
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--Tandem t:slim Mobile App authorized by Health Canada for iPhone and Android Phones. The app will be available for Canadian customers later this year.
Top 3 Health Care Stocks That Are Preparing To Pump This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Tandem Diabetes Care: An Earnings Miss Confirms The Bear Case - Downgrade To Sell
Downgrading Tandem Diabetes Care to sell after Q2 2025 earnings confirms core U.S. business weakness and deteriorating profitability. Intense competition from Insulet and Medtronic is eroding Tandem's...